BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10636954)

  • 1. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 2. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Raj L; Adhyaru B
    Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
    Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical treatment regimens for chronic heart failure: a review.
    Gould PA; Kaye DM
    Expert Opin Pharmacother; 2002 Nov; 3(11):1569-76. PubMed ID: 12437491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?
    Cleland JG
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():297-303. PubMed ID: 9211024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Options in drug combinations].
    Correia JM
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():39-49. PubMed ID: 11409073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
    Demopoulos L; Yeh M; Gentilucci M; Testa M; Bijou R; Katz SD; Mancini D; Jones M; LeJemtel TH
    Circulation; 1997 Apr; 95(7):1764-7. PubMed ID: 9107160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Am Heart J; 1998 Jun; 135(6 Pt 2 Su):S231-48. PubMed ID: 9630088
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
    Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
    Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
    Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1770-7. PubMed ID: 9410998
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Practical aspects of diagnosis, treatment and prognosis in chronic heart failure].
    Wagdi P
    Dtsch Med Wochenschr; 1999 Mar; 124(10):291-5. PubMed ID: 10191824
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in the pharmacotherapy of cardiac failure.
    Campbell TJ
    Med J Aust; 1992 Sep; 157(5):292-4. PubMed ID: 1359389
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of cardiac failure].
    Yamaguchi T
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):553-9. PubMed ID: 9577592
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological treatment of chronic heart failure.
    Adorisio R; De Luca L; Rossi J; Gheorghiade M
    Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.